Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias

Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA

$Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias ( Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA )$

6 Dec 2018

KRd versus VRd in patients with newly diagnosed multiple myeloma

Dr Ola Landgren - Memorial Sloan Kettering Cancer Centre, New York, USA

6 Dec 2018

Landscape change with oral proteasome maintenance in multiple myeloma patients

Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar Lonial

3 Dec 2018

Multiple myeloma highlights and more from ASH 2018

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France

3 Dec 2018

The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients

Dr Corinne Summers - Seattle Children's Hospital, Seattle, USA

2 Dec 2018

ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma

Dr Owen O'Connor - Columbia University Medical Centre, New York, USA

2 Dec 2018

Improving toxicity and outcomes by taking ibrutinib during and after CAR T-cell therapy for relapsed and/or refractory CLL

Dr Jordan Gauthier - Fred Hutchinson Cancer Research Centre, Seattle, USA

$Improving toxicity and outcomes by taking ibrutinib during and after CAR T-cell therapy for relapsed and/or refractory CLL ( Dr Jordan Gauthier - Fred Hutchinson Cancer Research Centre, Seattle, USA )$